Acceder

Cotización de Arcutis Biotherapeutics, Inc. (ARQT) hoy en tiempo real

Arcutis Biotherapeutics, Inc. (ARQT)

Análisis técnico y gráfico histórico de Arcutis Biotherapeutics, Inc.

Análisis fundamental y estadísticas clave de Arcutis Biotherapeutics, Inc.

Ficha de Arcutis Biotherapeutics, Inc. (ARQT)

Ticker ARQT
ISIN US03969K1088
Sector Atención sanitaria
Mercado NASDAQ

Análisis financiero de Arcutis Biotherapeutics, Inc.

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Arcutis Biotherapeutics, Inc.

Invertir en Arcutis Biotherapeutics, Inc. en 2026: Preguntas frecuentes

¿Qué es Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus k...

¿En qué sector opera Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.